Skip to main content
OpenTrials
Completed

NCT Number: NCT02383264

Splanchnic Oxygenation After the First Enteral Feed in Preterm Infants: Prediction of Feeding Tolerance.

Enteral nutrition of preterm and intrauterine growth-restricted (IUGR) infants is still a challenge for neonatologists. Due to the immaturity of the gastrointestinal tract, preterm infants are at high risk of developing feeding intolerance (FI) or necrotizing enterocolitis (NEC), which is the most feared gastrointestinal complication of prematurity. The occurrence of FI often prompts clinicians to withhold, decrease or discontinue enteral feeds; thus, the establishment of an adequate early enteral nutrition is frequently hampered. Early identification of preterm infants at high risk for gastrointestinal complications could help clinical decisions on the introduction and the advancement of enteral feeding.

Near-infrared spectroscopy (NIRS) provides a non-invasive monitoring of regional oxygen saturation (rSO2). A significant correlation between lower abdominal rSO2 values in the first week of life and subsequent NEC development has been reported. To date, however, splanchnic oxygenation patterns in response to the first bolus feed and possible correlations with subsequent FI development have not been yet established.

This observational prospective study aims:

* to assess abdominal rSO2 patterns in response to the first bolus feed; * to evaluate possible correlations with subsequent development of gastrointestinal complications.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 day–30 day

Sex eligibility

All sexes

Study type

Observational

Primary location

Neonatal Intensive Care Unit of the S.Orsola-Malpighi Hospital

Bologna, Italy, 40138

About this study

Enteral nutrition of preterm and intrauterine growth-restricted (IUGR) infants remains a major challenge for neonatologists. Early introduction of minimal enteral feeding (MEF) enhances gut hormones release, reduces the intestinal permeability and improves the motility of the intestinal tract, thus promoting gut functional maturation. Due to gastrointestinal immaturity, however, preterm infants are likely to develop clinical symptoms of feeding intolerance (FI), such as abdominal distention, vomiting, abundant and/or bilious gastric residuals, occult or gross bloody stools. FI could represent an early sign of necrotizing enterocolitis (NEC), the most feared gastrointestinal complication of prematurity. The occurrence of FI often prompts neonatologists to withhold, decrease or discontinue enteral feeds, thus hampering the establishment of an adequate early enteral nutrition.

Early identification of preterm infants at high risk of gastrointestinal complications could help clinical decisions on the introduction and the advancement of enteral feeding. The administration of the first feed in healthy preterm infants leads to a post-prandial increase of superior mesenteric artery (SMA) blood flow, detected by Doppler ultrasound. A significant correlation between early feeding tolerance and increased SMA blood flow velocity has been further observed one hour after the first feed.

Near-infrared spectroscopy (NIRS) provides a non-invasive monitoring of regional oxygen saturation (rSO2) and has been previously used to evaluate mesenteric perfusion in preterm infants at increased risk for intestinal complications. Abdominal rSO2 detected by NIRS has been shown to effectively reflect mesenteric blood flow changes. A significant correlation between lower abdominal rSO2 values in the first week of life and subsequent NEC development has been recently observed in a cohort of preterm infants, confirming previous data from animal models.

Current evidences on the role of NIRS monitoring in predicting FI development are still limited. To date, indeed, splanchnic oxygenation patterns in response to the first bolus feed and possible correlations with subsequent FI development have not been established yet.

The aim of this study is to assess abdominal rSO2 patterns in response to the first bolus feed and to evaluate possible correlations with the development of gastrointestinal complications.

Infants admitted to the Neonatal Intensive Care Unit (NICU) are consecutively enrolled in the study if fulfilling the following criteria: gestational age ≤34 weeks, stable clinical conditions, availability of antenatal Doppler data.

Exclusion criteria

are:

  • Enteral feeding prior to the enrollment
  • Major congenital abnormalities
  • Central nervous system diseases
  • Hypoxic injury
  • Hemodynamic instability, hypotension, patent ductus arterioles, anemia, sepsis or other infections at time of the first feed.
  • Antenatal Doppler impairment.

Written, informed consent to participate in the study is obtained from the parents/legal guardians of each infant before enrollment.

During the first feed administration, the enrolled infants undergo a continuous monitoring of cerebral and splanchnic rSO2 by means of an INVOS 5100 oximeter. NIRS recording is performed from 30 minutes before to 3 hours after feeding administration. Cerebral and splanchnic rSO2 are recorded every 5 seconds. Baseline values are defined by the mean of the 15 minutes before the meal; values recorded after feeding administration are clustered into 5-minute intervals.

Feeding intolerance is defined as enteral feeding withholding for at least 1 day due to the onset of gastrointestinal symptoms.

Patients' characteristics (including gestational age, birth weight, tolerance to enteral feeds during hospitalization) are recorded in a specific case report form at the time of enteral feeding introduction and before discharge.

In relation to their clinical characteristics, the enrolled infants are retrospectively allocated into 2 groups:

  • Group 1: infants developing FI during the hospitalization;
  • Group 2: infants not developing FI during the hospitalization;

Data are analyzed using IBM SPSS Statistic version 20.0.0 (IBM Corporation, IBM Corporation Armonk, New York, United States). Clinical characteristics in the study groups are compared by t-test for continuous variables and chi-square test for categorical variables. Mann-Whitney U test is used to compare abdominal rSO2 patterns in response to the first feed between groups 1 and 2. A multivariate analysis is also performed to assess the effect of possible confounding factors.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Gestational age ≤34 weeks
  • Stable clinical conditions

Exclusion criteria

  • Any enteral feeding prior to the enrollment.
  • Major congenital abnormalities
  • Central nervous system diseases
  • Hypoxic injury
  • Hemodynamic instability, hypotension, patent ductus arterioles, anemia, sepsis or other infections at time of first feed.
  • Antenatal Doppler impairment.

Treatment and study plan

Primary outcomes

  1. Increase/reduction of abdominal rSO2 values after the first enteral feed in infants at high risk of feeding intolerance.

    Time frame: 3.5 hours

    Increase/reduction of abdominal rSO2 values in response to the first enteral feed in infants who have further developed feeding intolerance during their hospitalization.

Sponsors and collaborators

Lead sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Other

Registry information

Official study title

Splanchnic Oxygenation Patterns in Response to the First Enteral Feed in Preterm Infants: Prediction of Feeding Tolerance and Correlation With Abnormal Antenatal Doppler.

Acronym: NIRS-SO

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Mar 9, 2015
Registry last updated
Nov 22, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.